Issue 2: Fall 2009

Introduction: contains Cover, Table of Contents, Letter from the Editor, and Masthead

Articles

4.   The Regulation of Nanomedicine: Will the Exisiting Regulatory Scheme of the FDA Suffice? — Shanna Harris

5.   Will the Federal Circuit’s Eli Lilly v. Teva Decision Lead to Efforts To Abuse the Modification Provision of the Hatch-Waxman Act? — Claire K. Comfort

6.   Dreadful Policing: Are the Semiconductor Industry Giants Content with Yesterday’s International Protection for Integrated Circuits? — Michael Fuerch

7.   Students’ Free Speech Rights Shed at the Cyber Gate — Vivian Lei